The increasing prevalence of endometrial resection devices and rise in awareness regarding the procedure are driving the demand for the market.
The global endometrial resection devices market is forecast to reach USD 1,617.2 Million by 2028, according to a new report by Reports and Data. Endometrial resection is a medical procedure which involves the removal of a woman’s lining of the uterus, i.e., endometrium, with an electrosurgical wire loop to prevent excessive bleeding during menstruation. In most cases, this procedure significantly reduces or stops blood flow.
This procedure is recommended when the uterine bleeding is no longer controlled by any other means or medications. This procedure is strictly not suitable for women who are suffering from disorders such as infections of the uterus, endometrial hyperplasia, pregnancy, and cancer of the uterus. The increase in gynecological disorders such as endometriosis and uterine myomas have resulted in patients opting for various surgical and diagnostic treatment. Rapid technological advances in the medical devices sector have led to the development and adoption of endometrial resection devices as treatment care.
Endometrial resection helps in curing various gynecological disorders such as abnormal vaginal bleeding, menorrhagia, and POCD or polycystic ovarian disease in women. Growing demand for minimally invasive surgical procedures, rising cases of various gynecological disorders, and burgeoning population suffering from abnormal vaginal bleeding are the major factors driving the global endometrial resection devices market.
North America leads the endometrial resection devices market. The region has witnessed rapid advancements in technology. With rising healthcare infrastructure, growing cases of gynecological disorders, and strong establishment of significant market players, endometrial resection devices are witnessing high demand in this region.
Get a sample copy of the global Endometrial Resection Devices market report @ https://www.reportsanddata.com/sample-enquiry-form/2485
Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.
Further key findings from the report suggest
Resectoscopic techniques are performed under hysteroscopic visualization, using resectoscopic instruments to resect the endometrium. These techniques are also referred to as standard or first-generation ablation. Non-resectoscopic endometrial ablation also referred to as second-generation ablation, is performed with a device that is inserted into the uterine cavity and delivers energy to destroy the uterine lining uniformly.
Cryotherapy ablation/resection is a minimally invasive procedure that involves using cold temperatures to freeze and destroy the lining of the womb. Studies said that this is one of the most common procedures used to destroy the endometrium, although different procedures use different ways of doing it.
Ambulatory surgery centers are same-daysurgery They are health care facilities where those surgical procedures are performed which do not require an overnight hospital stay. Such surgery is generally less complicated than that requiring hospitalization. Rise in minimally invasive surgery in endometrium resection has increased the trend of it, in the ambulatory surgery centers.
APAC provides lucrative opportunities for the market players operating in the endometrial resection devices market due to the increase in demand for minimally invasive procedures, and developments in healthcare infrastructure, and high population base, will drive the demand for endometrial resection techniques. A rise in awareness regarding menstrual complications and increase in healthcare expenditures in Asia Pacific makes this region to exhibit a substantially fast growth.
Key participants include Boston Scientific Corporation, Medtronic Plc., Ethicon US, Minerva Surgical, Cooper Surgical, RF Medical, MedGyn Inc., Biosense Webster Inc., Erbe Inc., and Hansen Medical Inc., among others.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2485
For the purpose of this report, Reports and Data have segmented into the global Endometrial Resection Devices Market on the basis of device type, resection method, end-users, and region:
Device Type Outlook (Revenue, USD Billion; 2020-2028)
Resection Method Outlook (Revenue, USD Billion; 2020-2028)
Radiofrequency electrosurgery ablation
Microwave energy ablation
Thermal balloon ablation
Circulated hot fluid ablation
End Users Outlook (Revenue, USD Billion; 2020-2028)
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Billion; 2020-2028)
Major Highlights of the Endometrial Resection Devices Market Report:
The Endometrial Resection Devices market analysis report offers an in-depth study of the potential market growth opportunities and challenges.
The report dives deeper into the market and explains the dynamic factors bolstering market growth.
The report deeply assesses the current, historical market size, market share, and revenue growth rates to offer accurate market projections for the forecast period.
The report analyzes the Endometrial Resection Devices market presence across major regions of the world.
It determines the production & consumption capacities and demand & supply dynamics of each regional market.
The report further illustrates the intense competition among the key market players and highlights their effective business expansion plans and strategies.
It provides company overview and SWOT analysis of each of the market players.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2485
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.
Read More Reports:-
Protein Binding Assays Market @ https://www.biospace.com/article/protein-binding-assays-market-size-to-reach-usd-710-8-million-in-2028/
Primary Care POC Diagnostics Market @ https://www.biospace.com/article/primary-care-poc-diagnostics-market-size-to-reach-usd-9-5-billion-in-2028-says-reports-and-data/
Neuroscience Antibodies and Assays Market @ https://www.biospace.com/article/neuroscience-antibodies-and-assays-market-size-to-reach-usd-7-06-billion-in-2028-says-reports-and-data-/
Clinical Microbiology Market @ https://www.biospace.com/article/clinical-microbiology-market-size-to-reach-usd-6-6-billion-in-2028-noted-reports-and-data/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370